ZolpiMist PDUFA date extended

FDA extended the review time for an NDA from NovaDel (AMEX:NVD) for ZolpiMist zolpidem oral spray for the short-term treatment of insomnia by three months to Dec. 19 from Sept. 21. The company said FD...